Integrated multi-omics analyses reveal candidate astrocytic signalling responses shared across pharmacologically distinct psychoactive compounds
Year: 2026
Type: article
Abstract: Astrocytes are increasingly recognised as contributors to the neuroadaptations that underlie substance use disorders, but most studies examine single drugs, and it remains unclear whether pharmacologically distinct substances engage a common astrocytic response. Here, we apply an integrated multi-omic approach to two human astrocyte-like cell lines, KNS-42 and SVG-A, exposed to ethanol, Δ9-tetrahydrocannabinol, cocaine, morphine or psilocin, to profile the transcriptome in both cell lines and the phosphoproteome and metabolome in KNS-42. Both cell lines expressed transcripts for several canonical targets of these compounds, including opioid (OPRM1, OPRD1) receptors and serotonin receptors and the astrocytic glutamate transporter SLC1A3, with the cannabinoid receptor CN1 and the glutamate transporter SLCA2 detected in KNS-42 cells only. KNS-42 and SVG-A diverged transcriptionally, as expected for developmentally distinct astrocytes. Despite this, the chemically distinct psychoactive compounds converged on a small set of candidate molecular features: seven phosphoproteins (including vimentin, MAP1B and AHNAK) and thirteen putatively annotated metabolite features, each representing greater overlap than expected by chance. The shared response across multi-omic layers implicated cytoskeletal and Rho-GTPase signalling, cell-cycle regulation and, putatively, nucleotide catabolism. Our findings indicate that distinct psychoactive compounds may converge on a small number of astrocytic processes and we provide an interactive data application for exploring astrocytic responses to psychoactive compounds.
Source: Scientific Reports
Institutions: University of Nottingham, Kyungpook National University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: astrocytes, psychoactive substances, substance use disorders, ethanol, tetrahydrocannabinol, cocaine, morphine, psilocin, transcriptome, phosphoproteome, metabolome, opioid receptors, serotonin receptors, glutamate transporters, vimentin, MAP1B, AHNAK, Rho GTPase signaling, cell cycle regulation, nucleotide catabolism, neural adaptation
Open Access status: gold
Estimated APC paid: $2,690
Funder: Wellcome Trust
OpenAlex ID: W7233524503
